Your browser doesn't support javascript.
loading
Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage.
Jones, Felipe J S; Sanches, Paula R; Smith, Jason R; Zafar, Sahar F; Blacker, Deborah; Hsu, John; Schwamm, Lee H; Newhouse, Joseph P; Westover, Michael B; Moura, Lidia M V R.
Afiliación
  • Jones FJS; Department of Neurology, Massachusetts General Hospital, Boston.
  • Sanches PR; Department of Neurology, Massachusetts General Hospital, Boston.
  • Smith JR; Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Zafar SF; Department of Neurology, Massachusetts General Hospital, Boston.
  • Blacker D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Hsu J; Department of Neurology, Massachusetts General Hospital, Boston.
  • Schwamm LH; Department of Neurology, Harvard Medical School, Boston, Massachusetts.
  • Newhouse JP; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Westover MB; Department of Psychiatry, Massachusetts General Hospital, Boston.
  • Moura LMVR; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
JAMA Neurol ; 78(9): 1128-1136, 2021 09 01.
Article en En | MEDLINE | ID: mdl-34309642
ABSTRACT
Importance Limited evidence is available concerning optimal seizure prophylaxis after spontaneous intracerebral hemorrhage (sICH).

Objective:

To evaluate which of 4 seizure prophylaxis strategies provides the greatest net benefit for patients with sICH. Design, Setting, and

Participants:

This decision analysis used models to simulate the following 4 common scenarios (1) a 60-year-old man with low risk of early (≤7 days after stroke) (10%) and late (3.6% or 9.8%) seizures and average risk of short- (9%) and long-term (30%) adverse drug reaction (ADR); (2) an 80-year-old woman with low risk of early (10%) and late (3.6% or 9.8%) seizures and high short- (24%) and long-term (80%) ADR risks; (3) a 55-year-old man with high risk of early (19%) and late (34.8% or 46.2%) seizures and low short- (9%) and long-term (30%) ADR risks; and (4) a 45-year-old woman with high risk of early (19%) and late (34.8% or 46.2%) seizures and high short- (18%) and long-term (60%) ADR risks.

Interventions:

The following 4 antiseizure drug strategies were included (1) conservative, consisting of short-term (7-day) secondary early-seizure prophylaxis with long-term therapy after late seizure; (2) moderate, consisting of long-term secondary early-seizure prophylaxis or late-seizure therapy; (3) aggressive, consisting of long-term primary prophylaxis; and (4) risk guided, consisting of short-term secondary early-seizure prophylaxis among low-risk patients (2HELPS2B score, 0), short-term primary prophylaxis among patients at higher risk (2HELPS2B score, ≥1), and long-term secondary therapy for late seizure. Main Outcomes and

Measures:

Quality-adjusted life-years (QALYs).

Results:

For scenario 1, the risk-guided strategy (8.13 QALYs) was preferred over the conservative (8.08 QALYs), moderate (8.07 QALYs), and aggressive (7.88 QALYs) strategies. For scenario 2, the conservative strategy (2.18 QALYs) was preferred over the risk-guided (2.17 QALYs), moderate (2.09 QALYs), and aggressive (1.15 QALYs) strategies. For scenario 3, the aggressive strategy (9.21 QALYs) was preferred over the risk-guided (8.98 QALYs), moderate (8.93 QALYs), and conservative (8.77 QALYs) strategies. For scenario 4, the risk-guided strategy (11.53 QALYs) was preferred over the conservative (11.23 QALYs), moderate (10.93 QALYs), and aggressive (8.08 QALYs) strategies. Sensitivity analyses suggested that short-term strategies (conservative and risk guided) are preferred under most scenarios, and the risk-guided strategy performs comparably to or better than alternative strategies in most settings. Conclusions and Relevance This decision analytical model suggests that short-term (7-day) prophylaxis dominates longer-term therapy after sICH. Use of the 2HELPS2B score to guide clinical decisions for initiation of short-term primary vs secondary early-seizure prophylaxis should be considered for all patients after sICH.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Convulsiones / Hemorragia Cerebral / Técnicas de Apoyo para la Decisión / Anticonvulsivantes Tipo de estudio: Prognostic_studies Límite: Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Convulsiones / Hemorragia Cerebral / Técnicas de Apoyo para la Decisión / Anticonvulsivantes Tipo de estudio: Prognostic_studies Límite: Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Año: 2021 Tipo del documento: Article